Lex­i­con dives ‘in­to the dark’ days fol­low­ing heart fail­ure hos­pi­tal­iza­tions with new cam­paign

3 years ago
Pharma
Marketing

Mer­ck’s oral cho­les­terol-low­er­ing drug shows sim­i­lar ef­fi­ca­cy to in­jectable pre­de­ces­sors as it moves to PhI­II: ...

3 years ago
R&D

Ac­cel­er­at­ed ap­proval in­com­ing? Mod­er­na 'hope­ful' for per­son­al­ized can­cer vac­cine

3 years ago
Pharma
FDA+

Thou­sands of com­plaints and lab records in 'bags of scrap': FDA in­spects Cipla site in In­dia

3 years ago
FDA+
Manufacturing

Or­chard lines up mon­ey for pro­posed Lib­meldy ex­pan­sion; Har­bour touts PhI­II

3 years ago
News Briefing

Men­tal health-fo­cused atai chops 30% of staff to 'fur­ther fo­cus' on loom­ing read­outs

3 years ago
People

With PhII suc­cess, Bridge­Bio wades deep­er in­to dwarfism drug de­bate

3 years ago
R&D

Aclaris shares halved af­ter mid-stage skin dis­or­der fail

3 years ago
R&D

French CAR-T biotech Mnemo Ther­a­peu­tics shut­ters US op­er­a­tions

3 years ago
People
Cell/Gene Tx

Red Tree, RA Cap­i­tal lead $108M in­fu­sion in­to Bicara and its bi­func­tion­al I/O drug

3 years ago
Financing

Months af­ter re­org, Adap­ti­m­mune merges with fel­low cell ther­a­py de­vel­op­er

3 years ago
Deals
Cell/Gene Tx

Voy­ager nabs $25M cash as No­var­tis runs with two AAV cap­sids for neu­ro gene ther­a­py

3 years ago
Deals
Cell/Gene Tx

In­cyte stops PhI­II tri­al for PI3K in­hibitor af­ter pri­ma­ry end­point fail­ure

3 years ago
R&D

Ju­ly de­ci­sion date set for full ap­proval of Ei­sai's Alzheimer's drug, with an ad­comm com­ing too

3 years ago
FDA+

Cy­to­ki­net­ic­s' heart drug shows pos­i­tive re­sults af­ter FDA re­jec­tion of ear­li­er treat­ment: #ACC23

3 years ago
R&D

Es­pe­ri­on un­veils long-await­ed da­ta on cho­les­terol pil­l's abil­i­ty to cut car­dio­vas­cu­lar risk: #ACC23

3 years ago
R&D
Pharma

What lat­est wave of lay­offs means for biotech; Ra­dio­ther­a­py short­age; De­liv­er­ing on mR­NA's promis­es; and more

3 years ago
Weekly

FDA is­sues new guid­ance on wet AMD drug de­vel­op­ment

3 years ago
Pharma
FDA+

Wal­greens de­cides against dis­trib­ut­ing abor­tion pill in some states — re­port

3 years ago
Pharma
FDA+

Q&A with Chris­tine Baed­er, new chair of the gener­ic in­dus­try’s AAM

3 years ago
Pharma
FDA+

Re­al Chem­istry in­tends to sync doc­tor and pa­tient mar­ket­ing with physi­cian-fo­cused agency ac­qui­si­tion

3 years ago
Pharma
Marketing

UK gov­ern­ment plans to hike rev­enue claw­back rates be­gin­ning in April

3 years ago
Financing
Pharma

Merz Aes­thet­ics hands the mic to Christi­na Aguil­era in Botox ri­val cam­paign

3 years ago
Pharma
Marketing

J&J’s Janssen calls on co­me­di­an to un­der­score mul­ti­ple myelo­ma in­equities in the Black com­mu­ni­ty

3 years ago
Pharma
Marketing
First page Previous page 379380381382383384385 Next page Last page
A service from the Financial Times